IMPPAT Phytochemical information: 
Tanshinone IIA

Tanshinone IIA
Clinical trials
Public title (as per ICTRP)Scientific title (as per ICTRP)Trial identifier
Efficacy and Safety of Sodium Tanshinone IIA Sulfonate (STS)on acute exacerbation of Chronic Obstructive Pulmonary Disease combined with Chronic Pulmonary Heart Disease:A Randomized controlled trialEfficacy and Safety of Sodium Tanshinone IIA Sulfonate (STS)on acute exacerbation of Chronic Obstructive Pulmonary Disease combined with Chronic Pulmonary Heart Disease:A Randomized controlled trialChiCTR-TRC-14005049
Therapeutic effects of tanshinone IIA towards early renal damage in patients with type 2 diabetesTherapeutic effects of tanshinone IIA towards early renal damage in patients with type 2 diabetesChiCTR-TQR-14005142
Clinical efficacy and safety evaluation of dissolving acupoint microneedles with tanshinone IIA in the treatment of chronic stable anginaClinical efficacy and safety evaluation of dissolving acupoint microneedles with tanshinone IIA in the treatment of chronic stable anginaChiCTR2400093487
Multi-center clinical study of sodium tanshinone IIA sulfonate on prognosis of patients with acute coronary syndromeMulti-center clinical study of sodium tanshinone IIA sulfonate on prognosis of patients with acute coronary syndromeChiCTR-TRC-14005182
Efficacy and Safety Study of Sodium Tanshinone IIA Sulfonate on Pulmonary HypertensionClinical Study of Effects of Sodium Tanshinone IIA Sulfonate on Pulmonary HypertensionNCT01637675
Effificacy of Sodium Tanshinone IIA Sulfonate combined with hydration pretreatment for prevention of contrast-induced acute kidney injury in patients after percutaneous coronary interventionEffificacy of Sodium Tanshinone IIA Sulfonate combined with hydration pretreatment for prevention of contrast-induced acute kidney injury in patients after percutaneous coronary interventionChiCTR2300070064
Sodium Tanshinone IIA Sulfonate in Left Ventricular Remodeling Secondary to Acute Myocardial InfarctionEffects of Sodium Tanshinone IIA Sulfonate on Left Ventricular Remodeling in Patients With ST-segment Elevation Myocardial Infarction Following Percutaneous Coronary InterventionNCT02524964